Stock Scorer

Selectis Health, Inc. (GBCS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 4M 8M 12M Q2 '21: 6M Q3 '21: 7.3M Q4 '21: 10.2M Q1 '22: 10.1M Q2 '22: 11.5M Q3 '22: 9.6M Q4 '22: 10.8M Q1 '23: 9.6M Q2 '23: 8.9M Q3 '23: 9M Q4 '23: 9.2M Q1 '24: 9.5M Q2 '24: 9.6M Q3 '24: 10M Q4 '24: 10.4M Q1 '25: 10.5M Q2 '25: 10.4M Q3 '25: 10.8M Q4 '25: 9.7M Q1 '26: 7.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Income Quarterly

-3M -1.5M 0 1.5M 3M 4.5M Q2 '21: 2.1K Q3 '21: 736.7K Q4 '21: -1.2M Q1 '22: 615.9K Q2 '22: 1.3M Q3 '22: -322.3K Q4 '22: -1.9M Q1 '23: -2M Q2 '23: -1.6M Q3 '23: -2.4M Q4 '23: -3M Q1 '24: -696.3K Q2 '24: -763.9K Q3 '24: -1.2M Q4 '24: -97.3K Q1 '25: -421.7K Q2 '25: -450.3K Q3 '25: -297K Q4 '25: -395.7K Q1 '26: -1.3M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income Quarterly

-5M -2.5M 0 2.5M 5M 7.5M Q2 '21: -678.8K Q3 '21: -53K Q4 '21: -1.8M Q1 '22: 37.1K Q2 '22: 750.2K Q3 '22: -990.9K Q4 '22: -2.2M Q1 '23: 4M Q2 '23: -2.1M Q3 '23: -2.3M Q4 '23: -3.6M Q1 '24: -1M Q2 '24: 794.3K Q3 '24: -1.6M Q4 '24: -576.5K Q1 '25: -656K Q2 '25: -308K Q3 '25: 752.4K Q4 '25: -804.1K Q1 '26: 6.5M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Cash Flow Quarterly

-2.7M -1.8M -900K 0 900K 1.8M 2.7M Q1 '21: -664.8K Q2 '21: 22.5K Q3 '21: -962.4K Q4 '21: 1.3M Q1 '22: -1.2M Q2 '22: 1.3M Q3 '22: -752.1K Q4 '22: 345.5K Q1 '23: -67K Q2 '23: 99.6K Q3 '23: 2.4M Q1 '24: 249.5K Q2 '24: -422.9K Q3 '24: -1.2M Q4 '24: -423.4K Q1 '25: 1M Q2 '25: -77.4K Q3 '25: 280K Q4 '25: 644K Q1 '26: -2.3M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow Quarterly

-3M -2M -1M 0 1M 2M 3M Q3 '20: 865.2K Q1 '21: -842.8K Q2 '21: -195.2K Q3 '21: -1.1M Q4 '21: 1.3M Q1 '22: -1.3M Q2 '22: 1.3M Q3 '22: -991.7K Q1 '23: -109.5K Q2 '23: 99.6K Q3 '23: 2.3M Q1 '24: 132.9K Q2 '24: -512.7K Q3 '24: -1.2M Q4 '24: -433.2K Q1 '25: 816.2K Q2 '25: -240.9K Q3 '25: 275.8K Q4 '25: 587.3K Q1 '26: -2.7M Q1 '21 Q4 '21 Q3 '22 Q3 '23 Q3 '24 Q2 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 10M 20M 30M Q3 '19: 27.4M Q1 '20: 27.4M Q2 '20: 27.8M Q3 '20: 3.1M Q1 '21: 2.8M Q2 '21: 2.7M Q3 '21: 2.8M Q1 '22: 3.1M Q2 '22: 3.1M Q3 '22: 3.1M Q1 '23: 3.1M Q2 '23: 3.1M Q3 '23: 3.1M Q1 '24: 3.1M Q2 '24: 3.1M Q3 '24: 3.1M Q1 '25: 3.1M Q2 '25: 3.1M Q3 '25: 3.1M Q1 '26: 3.4M Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '20: 0.01 Q3 '20: 0.15 Q4 '20: 0.61 Q1 '21: 0.70 Q2 '21: 0.40 Q3 '21: 0.23 Q4 '21: -0.83 Q1 '23: 0.61 Q2 '23: -0.42 Q3 '23: -0.83 Q4 '23: -1.31 Q1 '24: -2.97 Q2 '24: -2.02 Q3 '24: -1.80 Q4 '24: -0.80 Q1 '25: -0.68 Q2 '25: -1.04 Q3 '25: -0.28 Q4 '25: -0.34 Q1 '26: 1.78 Q3 '20 Q2 '21 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for GBCS: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.